Author

P. Mirmirani

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Dose optimization of deuruxolitinib in adults with alopecia areata: A phase 2 randomized trial.

BACKGROUND The autoimmune disorder alopecia areata (AA) results in patchy or complete hair loss. OBJECTIVE To evaluate the efficacy and safety of the Janus kinase 1/2 inhibitor deuruxolitinib dosed 8 mg twice daily (BID) or 16 mg once daily (QD) in adults with severe AA. METHODS In this phase 2 study (NCT03811912),...

Brett King, Steven Kempers, N. Mesinkovska et al. · Journal of American Academy... · 0 citations

Review Open access Sep 2026

Characteristics of Emergency Department Patients Seeking Dermatologic Care Using 2022 National Hospital Ambulatory Medical Care Survey Data

Emergency department (ED) visits often serve as a safety net for patients with limited access to outpatient dermatologic care. Racial and ethinci minorities experience disproportionate barriers to dermatologic diagnosis, treatment, and specialty access. We evaluated racial/ethnic differences in ED visits identifying pr...

A. Gomez-Lara, N. Vargas, J. Castillo et al. · SKIN The Journal of Cutaneou... · 0 citations